Skip to main content
Premium Trial:

Request an Annual Quote

That's One Way to Cut Down on Negative Findings

The New York Times reports on a complaint filed by academic researchers who say that biotech companies are preventing them from "fully researching the effectiveness and environmental impact of the industry's genetically modified crops," the article says. (You can also check out the statement they submitted to EPA.) "The problem, the scientists say, is that farmers and other buyers of genetically engineered seeds have to sign an agreement meant to ensure that growers honor company patent rights and environmental regulations. But the agreements also prohibit growing the crops for research purposes," the story says.

According to the Times, EPA will be holding scientific meetings on biotech crops this week, and is looking for public comment on this topic.

Stephen Albainy-Jenei at Patent Baristas blogs about the issue as well, noting that while scientists looking to study these crops "can ask for permission from the seed companies, permission is sometimes denied or the company insists on the right to have an advance review of the studies' results before they can be published."

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.